BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 4780697)

  • 1. Identity of 'acid' beta-glucosidase and glucocerebrosidase in human spleen.
    Ho MW
    Biochem J; 1973 Nov; 136(3):721-9. PubMed ID: 4780697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical and kinetic properties of beta-glucosidase in Gaucher disease.
    Karazeh A; Carroll M
    J Inherit Metab Dis; 1983; 6(3):101-4. PubMed ID: 6422137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gaucher's disease II. Studies on the kinetics of beta-glucosidase and the effects of sodium taurocholate in normal and Gaucher tissues.
    Choy FY; Davidson RG
    Pediatr Res; 1980 Jan; 14(1):54-9. PubMed ID: 6767218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of beta-glucocerebrosidase from beta-glucosidase in human tissues using sodium taurocholate.
    Peters SP; Coyle P; Glew RH
    Arch Biochem Biophys; 1976 Aug; 175(2):569-82. PubMed ID: 958319
    [No Abstract]   [Full Text] [Related]  

  • 5. Purification and properties of a heat-stable glucocerebrosidase activating factor from control and Gaucher spleen.
    Peters SP; Coyle P; Coffee CJ; Glew RH
    J Biol Chem; 1977 Jan; 252(2):563-73. PubMed ID: 13071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzymic differentiation of neurologic and nonneurologic forms of Gaucher's disease.
    Glew RH; Daniels LB; Clark LS; Hoyer SW
    J Neuropathol Exp Neurol; 1982 Nov; 41(6):630-41. PubMed ID: 6813430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gaucher's disease: deficiency of 'acid' -glucosidase and reconstitution of enzyme activity in vitro.
    Ho MW; O'Brien JS
    Proc Natl Acad Sci U S A; 1971 Nov; 68(11):2810-3. PubMed ID: 5288260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The occurrence of two immunologically distinguishable beta-glucocerebrosidases in human spleen.
    Aerts JM; Donker-Koopman WE; van der Vliet MK; Jonsson LM; Ginns EI; Murray GJ; Barranger JA; Tager JM; Schram AW
    Eur J Biochem; 1985 Aug; 150(3):565-74. PubMed ID: 4018098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gaucher disease (type 1): physical and kinetic properties of liposomal and soluble 'acid' beta-glucosidase.
    Carroll M
    J Inherit Metab Dis; 1985; 8(1):33-7. PubMed ID: 3921758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple forms of membrane-bound beta-glucosidase in Gaucher's disease.
    Yaqoob M; Carroll M
    Clin Genet; 1981 Aug; 20(2):161-7. PubMed ID: 6796311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Separation by electrofocusing of the molecular forms of splenic beta-glucosidase in normal subjects and Gaucher's disease].
    Maret A; Salvayre R; Nègre A; Douste-Blazy L
    Biomedicine; 1980 May; 33(3):82-6. PubMed ID: 6778520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of N-acyl phosphatidylethanolamines with different N-acyl groups as activators of glucocerebrosidase in various forms of Gaucher's disease.
    Basu A; Prence E; Garrett K; Glew RH; Ellingson JS
    Arch Biochem Biophys; 1985 Nov; 243(1):28-34. PubMed ID: 3933429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A kinetic study of the effects of galactocerebroside 3-sulphate on human spleen glucocerebrosidase. Evidence for two activator-binding sites.
    Prence EM; Garrett KO; Glew RH
    Biochem J; 1986 Aug; 237(3):655-62. PubMed ID: 3800908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity in human acid beta-glucosidase revealed by cellulose-acetate electrophoresis.
    Sa Miranda MC; Aerts JM; Pinto RA; Magalhaes JA; Barranger JA; Tager JM; Schram AW
    Biochim Biophys Acta; 1988 May; 965(2-3):163-8. PubMed ID: 3130106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The occurrence of beta-glucocerebrosidase activity in the glucocerebroside-rich deposits of Gaucher's disease.
    Glew RH; Christopher AR; Schnure FW; Lee RE
    Arch Biochem Biophys; 1974 Jan; 160(1):162-7. PubMed ID: 4364062
    [No Abstract]   [Full Text] [Related]  

  • 16. Cell-specific differences in membrane beta-glucosidase from normal and Gaucher cells.
    Turner BM; Beratis NG; Hirschhorn K
    Biochim Biophys Acta; 1977 Feb; 480(2):442-9. PubMed ID: 13844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of activators and inhibitors to define the properties of the active site of normal and Gaucher disease lysosomal beta-glucosidase.
    Gatt S; Dinur T; Osiecki K; Desnick RJ; Grabowski GA
    Enzyme; 1985; 33(2):109-19. PubMed ID: 3924590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrolytic and transglucosylation activities of a purified calf spleen beta-glucosidase.
    Kanfer JN; Raghavan SS; Mumford RA
    Biochim Biophys Acta; 1975 May; 391(1):129-40. PubMed ID: 237551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of a heat-stable factor in human spleen on glucocerebrosidase and acid -glucosidase activities.
    Pentchev PG; Brady RO
    Biochim Biophys Acta; 1973 Feb; 297(2):491-6. PubMed ID: 4705477
    [No Abstract]   [Full Text] [Related]  

  • 20. Activators of spleen glucocerebrosidase from controls and patients with various forms of Gaucher's disease.
    Basu A; Glew RH; Daniels LB; Clark LS
    J Biol Chem; 1984 Feb; 259(3):1714-9. PubMed ID: 6693432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.